Consolidated Balance Sheets - USD ($)	Dec. 31, 2019	Dec. 31, 2018
Current assets
Cash and cash equivalents	$ 53,139	$ 68,513
Receivables	52,603	14,516
Total current assets	105,742	83,029
Investment in equity method investee	25,000	450,683
TOTAL ASSETS	130,742	533,712
Current liabilities
Accounts payable and accrued liabilities	175,243	225,430
Due to related parties	11,650	11,750
Convertible notes payable, net of discount	161,404	20,000
Derivative liability	262,712
Settlement liability	106,961	360,756
Total current liabilities	717,970	617,936
Convertible notes payable, net of discount - Long term
Total liabilities	717,970	617,936
Stockholders' deficit
Common stock; $0.0001 par value; 100,000,000 shares authorized; 17,153,936 and 2,435,179 shares issued and outstanding as of December 31, 2019 and 2018, respectively.	1,715	446
Additional paid-in capital	18,570,178	15,404,716
Accumulated deficit	(19,159,721)	(15,489,993)
Total Stockholders' deficit	(587,228)	(84,224)
TOTAL LIABILITIES AND STOCKHOLDER'S DEFICIT	130,742	533,712
Series A Preferred Stock [Member]
Stockholders' deficit
Preferred stock, value	400	400
Series B Preferred Stock [Member]
Stockholders' deficit
Preferred stock, value	0	7
Series C Preferred Stock [Member]
Stockholders' deficit
Preferred stock, value	$ 200	$ 200